M. A. N. Sendur Et Al. , "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma," INDIAN JOURNAL OF PHARMACOLOGY , vol.46, no.1, pp.125-126, 2014
Sendur, M. A. N. Et Al. 2014. Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma. INDIAN JOURNAL OF PHARMACOLOGY , vol.46, no.1 , 125-126.
Sendur, M. A. N., AKSOY, S., Ozdemir, N. Y., & Zengin, N., (2014). Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma. INDIAN JOURNAL OF PHARMACOLOGY , vol.46, no.1, 125-126.
Sendur, Mehmet Et Al. "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma," INDIAN JOURNAL OF PHARMACOLOGY , vol.46, no.1, 125-126, 2014
Sendur, Mehmet A. Et Al. "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma." INDIAN JOURNAL OF PHARMACOLOGY , vol.46, no.1, pp.125-126, 2014
Sendur, M. A. N. Et Al. (2014) . "Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma." INDIAN JOURNAL OF PHARMACOLOGY , vol.46, no.1, pp.125-126.
@article{article, author={Mehmet A. N. Sendur Et Al. }, title={Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma}, journal={INDIAN JOURNAL OF PHARMACOLOGY}, year=2014, pages={125-126} }